Literature DB >> 7698566

Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition.

B Messing1, M Lémann, P Landais, M C Gouttebel, M Gérard-Boncompain, F Saudin, A Vangossum, P Beau, C Guédon, D Barnoud.   

Abstract

BACKGROUND/AIMS: Long-term survival of patients with intestinal failure requiring home parenteral nutrition (HPN) has been only partly shown. Therefore, we described the survival of these patients and explored prognosis factors.
METHODS: Two hundred seventeen noncancer non-acquired immunodeficiency syndrome adult patients presenting with chronic intestinal failure enrolled from January 1980 to December 1989 in approved HPN programs in Belgium and France; prognosis factors of survival were explored using multivariate analysis. Data were updated in March 1991; not one of the patients was lost to follow-up.
RESULTS: Seventy-three patients died during the survey, and the mortality rate related to HPN complications accounted for 11% of deaths. Probabilities of survival at 1, 3, and 5 years were 91%, 70%, and 62%, respectively. Three independent variables were associated with a decreased risk of death: age of patients younger than 40 years, start of HPN after 1987, and absence of chronic intestinal obstruction. In patients younger than 60 years of age included after 1983 with a very short bowel, who could represent suitable candidates for small bowel transplantation, the 2-year survival rate was 90%, a prognosis that compared favorably with recent reports of survival after small bowel transplantation.
CONCLUSIONS: HPN prognosis compares favorably with recent reports of survival after small bowel transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7698566     DOI: 10.1016/0016-5085(95)90196-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Small Bowel Dysmotility.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

3.  Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.

Authors:  Bharati Kochar; Millie D Long; Edward Shelton; Lorraine Young; Francis A Farraye; Vijay Yajnik; Hans Herfarth
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

4.  Comparison of massive vs. repeated resection leading to short bowel syndrome.

Authors:  J S Thompson
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

5.  Guidelines for management of patients with a short bowel.

Authors:  J Nightingale; J M Woodward
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

6.  Reconnection surgery in adult post-operative short bowel syndrome < 100 cm: is colonic continuity sufficient to achieve enteral autonomy without autologous gastrointestinal reconstruction? Report from a single center and systematic review of literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

Review 7.  Small bowel motility: ready for prime time?

Authors:  E E Soffer
Journal:  Curr Gastroenterol Rep       Date:  2000-10

8.  Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome.

Authors:  Simon P Horslen; Debra L Sudan; Kishore R Iyer; Stuart S Kaufman; Angie K Iverson; Ira J Fox; Byers W Shaw; Alan N Langnas
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

9.  Managing the Adult Patient With Short Bowel Syndrome.

Authors:  Carol Rees Parrish; John K DiBaise
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-10

10.  Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition.

Authors:  G Zoli; G R Corazza; S Wood; R Bartoli; G Gasbarrini; M J Farthing
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.